← Leaderboards
John H Eldridge
University Of Alabama At Birmingham
$16,167,741
Attributed
$19,413,925
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2012–23$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,413,925 · 8
By mechanism
U19$12,353,270 · 4
R01$5,335,752 · 1
R56$1,156,616 · 1
R43$300,000 · 1
P01$268,287 · 1
Top collaborators
- Thomas William Geisbert5 shared
- John Rose1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Lauretta W Gerrity$4,683,708
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesVirusUnited States National Institutes Of HealthEbola VirusAreaNational Institute Of Allergy And Infectious DiseaseCenters For Disease Control And Prevention (U.S.)ImmunogenicityDisease OutbreaksSafetyRecombinantsToxicologyCategoriesDoseVesicular Stomatitis Indiana VirusVectorBaseVirus DiseasesLaboratoriesClinical TrialsCyclic GmpAttenuatedVaccine DeliverySeeds
Grant awards (23)
Project 1 - Profectus Biosciences, Inc.$867,787
U19 · FY2023 · AI · contact PI
Research Project 1: Vaccine for Rapid Response to Filovirus Outbreak$874,537
U19 · FY2022 · AI · contact PI
Project 1 - Profectus Biosciences, Inc.$802,301
U19 · FY2022 · AI · contact PI
Research Project 1: Vaccine for Rapid Response to Filovirus Outbreak$963,069
U19 · FY2021 · AI · contact PI
Project 1 - Profectus Biosciences, Inc.$864,462
U19 · FY2021 · AI · contact PI
Project 1 - Profectus Biosciences, Inc.$839,059
U19 · FY2020 · AI · contact PI
Project 1 - Profectus Biosciences, Inc.$805,740
U19 · FY2019 · AI · contact PI
Research Project 1: Vaccine for Rapid Response to Filovirus Outbreak$742,798
U19 · FY2019 · AI · contact PI
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection$263,375
U19 · FY2018 · AI · contact PI
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection$244,952
U19 · FY2017 · AI · contact PI
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection$2,733,163
U19 · FY2016 · AI · contact PI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses$1,208,817
R01 · FY2016 · AI · contact PI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses$947,203
R01 · FY2015 · AI · contact PI
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection$797,292
U19 · FY2015 · AI · contact PI
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection$1,554,735
U19 · FY2014 · AI · contact PI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses$937,397
R01 · FY2014 · AI · contact PI
Development of Chimeric Vesiculo/Alphaviruses as an Alphavirus Vaccine$1,156,616
R56 · FY2013 · AI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses$1,122,164
R01 · FY2013 · AI · contact PI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses$1,120,171
R01 · FY2012 · AI · contact PI
Prime/Boost Vaccine to Prevent Hepatocellular Carcinoma$300,000
R43 · FY2012 · CA · contact PI
ANTIGEN DELIVERY SYSTEM FOR HIV AND SIV VACCINES$0
P01 · FY2002 · AI
ANTIGEN DELIVERY SYSTEM FOR HIV AND SIV VACCINES$0
P01 · FY2001 · AI
ANTIGEN DELIVERY SYSTEM FOR HIV AND SIV VACCINES$268,287
P01 · FY2000 · AI